Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Takakura

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Cancer Gene Therapy|August 8, 2009
Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal disseminationM Takakura, M Nakamura, S Kyo, et al.
British Journal of Cancer|July 29, 2010
Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancerN Mori, S Kyo, M Nakamura, et al.
Oncogene|April 26, 2006
Creation of tumorigenic human endometrial epithelial cells with intact chromosomes by introducing defined genetic elementsY Mizumoto, S Kyo, S Ohno, et al.
The Journal of Pathology|August 16, 2006
Distinct telomere length regulation in premalignant cervical and endometrial lesions: implications for the roles of telomeres in uterine carcinogenesisY Maida, S Kyo, N R Forsyth, et al.
Cancer Research|October 18, 2000
Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathwayZ Wang, S Kyo, M Takakura, et al.
British Journal of Cancer|June 28, 2012
Circulating tumour cells detected by a novel adenovirus-mediated system may be a potent therapeutic marker in gynaecological cancersM Takakura, S Kyo, M Nakamura, et al.
Cancer Research|August 2, 2001
Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoterT Komata, Y Kondo, T Kanzawa, et al.
Science Advances|March 27, 2021
Loss of Ftsj1 perturbs codon-specific translation efficiency in the brain and is associated with X-linked intellectual disabilityY Nagayoshi, T Chujo, S Hirata, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Cancer Gene Therapy|August 8, 2009
Intraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal disseminationM Takakura, M Nakamura, S Kyo, et al.
British Journal of Cancer|July 29, 2010
Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancerN Mori, S Kyo, M Nakamura, et al.
Oncogene|April 26, 2006
Creation of tumorigenic human endometrial epithelial cells with intact chromosomes by introducing defined genetic elementsY Mizumoto, S Kyo, S Ohno, et al.
The Journal of Pathology|August 16, 2006
Distinct telomere length regulation in premalignant cervical and endometrial lesions: implications for the roles of telomeres in uterine carcinogenesisY Maida, S Kyo, N R Forsyth, et al.
Cancer Research|October 18, 2000
Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathwayZ Wang, S Kyo, M Takakura, et al.
British Journal of Cancer|June 28, 2012
Circulating tumour cells detected by a novel adenovirus-mediated system may be a potent therapeutic marker in gynaecological cancersM Takakura, S Kyo, M Nakamura, et al.
Cancer Research|August 2, 2001
Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoterT Komata, Y Kondo, T Kanzawa, et al.
Science Advances|March 27, 2021
Loss of Ftsj1 perturbs codon-specific translation efficiency in the brain and is associated with X-linked intellectual disabilityY Nagayoshi, T Chujo, S Hirata, et al.
Pageof 6